Global  

AstraZeneca to make billion COVID vaccine doses if tests succeed

Video Credit: Reuters Studio - Duration: 01:20s - Published
AstraZeneca to make billion COVID vaccine doses if tests succeed

AstraZeneca to make billion COVID vaccine doses if tests succeed

AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on Thursday it should shortly get results of an early stage clinical trial.

Ciara Lee reports

0
shares
ShareTweetSavePostSend
 

A billion doses of a possible COVID-19 vaccine, to be available this year and next.

That's AstraZeneca's plan if tests are successful.

The pharmaceutical company on Thursday (May 21) added that it should shortly get results of an early stage clinical trial.

The British drugmaker has already signed the first agreements to supply at least 400 million doses of the vaccine, which it is developing with Oxford University.

It's said that if results from the early stage tests are positive, they will lead to late stage trials in several countries.

Only a handful of vaccines in development have advanced to human trials.

That stage is seen as an indicator of safety and efficacy.

But it's the point when many new drugs fail.

Governments, drugmakers and researchers around the world are working on around 100 programs. Though experts warn it could take 12 to 18 months to develop a vaccine.

AstraZeneca also said it had received more than $1 billion from the U.S. Biomedical Advanced Research and Development Authority towards the potential treatment.

Other drugmakers including Pfizer, Johnson & Johnson and Sanofi are also in various stages of vaccine development.

AstraZeneca said it was engaging with international bodies over the fair allocation and distribution of any new product around the world.




💡 One News Page Knowledge: Other News Mentions

AstraZeneca AstraZeneca British-Swedish pharmaceutical company

Sanofi eyes vaccine approval by early 2021 [Video]

Sanofi eyes vaccine approval by early 2021

French drugmaker Sanofi expects to get approval for the potential coronavirus vaccine it is developing with GlaxoSmithKline by the first half of next year. Francis Maguire reports.

Credit: Reuters Studio    Duration: 01:13Published
AstraZeneca shares down after report it approached Gilead [Video]

AstraZeneca shares down after report it approached Gilead

Shares in Britain's AstraZeneca opened lower on Monday after a report it had approached U.S. rival Gilead Sciences about a possible merger. Ciara Lee reports

Credit: Reuters Studio    Duration: 01:09Published
COVID-19 vaccine "won't be expensive", developer says [Video]

COVID-19 vaccine "won't be expensive", developer says

A keenly-watched COVID-19 vaccine will be priced to allow as wide as possible access to it, if it proves successful, and will be made at huge scale to keep costs down and supply up, said the Oxford University professor co-leading its development. Emer McCarthy reports.

Credit: Reuters Studio    Duration: 01:28Published

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

HM Shah praises security forces for their efforts in COVID-19 battle [Video]

HM Shah praises security forces for their efforts in COVID-19 battle

Home Minister Shah on July 12 at tree plantation drive of Central Armed Police Forces in Gurugram praised security forces for their efforts in COVID battle. "India is one of the most populous countries. Everyone thought how will a country like India battle COVID19, there were apprehensions but today the whole world is witnessing how one of the most successful battles against COVID19 has been fought here," said Union Home Minister Amit Shah."In India's battle against COVID19, all of our security forces are playing a huge role, nobody can deny it. Today, I salute these corona warriors. They have proved that they not only know how to fight terrorism but also against COVID with help of people," he further added. Union Home Minister Amit Shah participated in the 'All India Tree Plantation Campaign' run by the Central Armed Police Forces in Gurugram.

Credit: ANI    Duration: 01:47Published
COVID: Hyderabad entrepreneur develops software to track availability of beds [Video]

COVID: Hyderabad entrepreneur develops software to track availability of beds

Hyderabad-based entrepreneur Arun Varma, has developed 'covidbedavailability.in', a software to help COVID-19 patients to locate hospitals with bed availability. He said, "This solution is designed for Govt to run their war rooms, control rooms and hospitals." Objective behind the development was to help patients to easily access information. A total of 32,224 confirmed cases have been recorded in Telangana so far.

Credit: ANI    Duration: 02:08Published
Amitabh Bachchan stable with mild COVID symptoms [Video]

Amitabh Bachchan stable with mild COVID symptoms

Legendary actor Amitabh Bachchan is stable with mild symptoms and is currently admitted in the isolation unit of the Nanavati Super Speciality Hospital. He tested positive for COVID-19 yesterday. His son and actor Abhishek Bachchan also tested positive.

Credit: ANI    Duration: 01:11Published

Oxford University Police Oxford University Police

Brazil to become testing ground for coronavirus vaccine

Shares Brazil may be struggling in its battle against the coronavirus, but it is on the cutting edge of vaccine development with large-scale trials and the..
WorldNews
Malala Yousafzai Graduates Oxford University [Video]

Malala Yousafzai Graduates Oxford University

CNN reports that Malala Yousafzai, has graduated from Oxford University. She and her family celebrated, with cake and confetti. Malala, is a 22-year-old Nobel Peace Prize winner, who lived after being shot in the head at 15 by the Taliban. Born in Pakistan, Malala is an activist who speaks out about girls education and human rights. On Friday Malala tweeted, "Hard to express my joy and gratitude right now as I completed my Philosophy, Politics and Economics degree at Oxford.

Credit: Wochit News    Duration: 00:41Published
British protesters target symbols of slavery and empire [Video]

British protesters target symbols of slavery and empire

Protesters in Oxford demanded the removal of a statue of colonialist Cecil Rhodes, while in London, a slave-trader's statue was targeted as part of protests against symbols of the slave trade and empire.

Credit: Reuters Studio    Duration: 02:01Published

Biomedical Advanced Research and Development Authority Biomedical Advanced Research and Development Authority Government organization in Washington D.C., United States

'Everything he's complaining about was achieved' -HHS Secretary on whistleblower [Video]

'Everything he's complaining about was achieved' -HHS Secretary on whistleblower

U.S. Health and Human Services Secretary Alex Azar on Thursday disputed whistleblower Richard Bright's testimony before a House of Representatives panel about the Trump administration's response to the coronavirus pandemic.

Credit: Reuters Studio    Duration: 01:45Published
Ousted health official to warn of 'darkest winter' [Video]

Ousted health official to warn of 'darkest winter'

Dramatic testimony is expected Thursday from an ousted health official who has accused the Trump administration of downplaying the coronavirus threat - and says he was pushed out when he voiced concerns. Lisa Bernhard has more.

Credit: Reuters - Politics    Duration: 02:15Published

Johnson & Johnson Johnson & Johnson U.S. multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

Johnson & Johnson Cease Production Of Lightening Products [Video]

Johnson & Johnson Cease Production Of Lightening Products

The corporation behind Johnson's, Neutrogena, Clean & Clear, and more has just vowed to stop selling two lines of skin-care products used for skin-lightening overseas. On June 19, in the wake of the recent Black Lives Matter uprising, Johnson & Johnson said that it will cease production of two different lines from Asian and Middle Eastern markets that were used for skin-lightening lines.

Credit: Wochit News    Duration: 00:33Published
Band-Aid to Make Black and Brown Flesh-Tone Bandages [Video]

Band-Aid to Make Black and Brown Flesh-Tone Bandages

The Johnson & Johnson-owned company plans to create a range of bandages to "embrace the beauty of diverse skin"

Credit: Cover Video STUDIO    Duration: 00:50Published
Johnson & Johnson Speeds Up Vaccine Timeline [Video]

Johnson & Johnson Speeds Up Vaccine Timeline

Johnson & Johnson plans to start testing its coronavirus vaccine candidate in humans in July. The company said it will move up the timeline by about two months to start clinical trials. Previously the aim was to enter the clinic with the vaccine in September. The study will start in the second half of July and enroll 1,045 healthy volunteers in the US and Belgium. If the vaccine works, Johnson & Johnson has already pledged to distribute it at a nonprofit rate to help end the pandemic.

Credit: Wochit News    Duration: 00:35Published
Johnson & Johnson to Begin Human Trials for COVID-19 Vaccine [Video]

Johnson & Johnson to Begin Human Trials for COVID-19 Vaccine

The early-stage human trial will begin in the second half of July as opposed to its initial forecast of September.

Credit: Cover Video STUDIO    Duration: 00:56Published
Johnson & Johnson Moves Up Dates Of Human Testing For Covid Vaccine (1) [Video]

Johnson & Johnson Moves Up Dates Of Human Testing For Covid Vaccine (1)

Johnson & Johnson is the world's largest health care company. Business Insider reports that the company plans to start testing its coronavirus vaccine candidate in humans in July. On Wednesday, Johnson & Johnson it will move up the timeline by about two months to start clinical trials. It was previously aiming for trials in September. 1,045 healthy volunteers in the US and Belgium will join the study, which starts in July.

Credit: Wochit News    Duration: 00:34Published

Sanofi Sanofi French pharmaceutical company

Sanofi invests €610 million in French vaccine research and production [Video]

Sanofi invests €610 million in French vaccine research and production

Sanofi invests €610 million in French vaccine research and production

Credit: Euronews English    Duration: 02:09Published

Pfizer Pfizer American multinational pharmaceutical corporation

Stocks rise on recovery hopes [Video]

Stocks rise on recovery hopes

U.S. stocks posted gains Monday as signs of U.S. economic recovery helped offset jitters over increasingly violent social unrest amid an ongoing pandemic and rising U.S.-China tensions. Fred Katayama reports.

Credit: Reuters Studio    Duration: 01:22Published

You Might Like

Related news from verified sources

U.S. Pledges $1.2 Billion For Experimental Vaccine Doses

U.S. Pledges $1.2 Billion For Experimental Vaccine Doses Watch VideoAs the race for a COVID-19 vaccine continues, the U.S. has pledged $1.2 billion to British...
Newsy - Published Also reported by •Reuters


AstraZeneca partners with Oxford Biomedica to expand COVID-19 vaccine manufacturing capacity

AstraZeneca has partnered with British cell therapy company Oxford Biomedica to make its experimental...
Reuters India - Published Also reported by •Belfast TelegraphReutersSeattle Times



Tweets about this

rubengarciaes

Ruben Garcia COVID-19: British drugmaker AstraZeneca aiming to make 2 billion doses of vaccine starting this September – CEO Eas… https://t.co/UFSJl7mDB3 3 days ago

chaselionsway

nobody RT @Sgmrpharma: AstraZeneca to make billion COVID vaccine doses if tests succeed The first agreements have been signed to supply at least… 1 week ago

Sgmrpharma

SGMR Pharmaceuticals Pvt. Ltd. AstraZeneca to make billion COVID vaccine doses if tests succeed The first agreements have been signed to supply a… https://t.co/xWNN9ZwnVt 1 week ago

WendyMc41783380

Wozel123 RT @CV2175911874: 2 Billion doses by September of what, something that has not been tested properly, totally been rushed through and might… 1 week ago

CV2175911874

Unknown_Traveler 2 Billion doses by September of what, something that has not been tested properly, totally been rushed through and… https://t.co/7XqXhnygtB 1 week ago


Related videos from verified sources

U.S. Gives $1.6B to Novavax to Deliver 100M Doses of Potential COVID-19 Vaccine by 2021 [Video]

U.S. Gives $1.6B to Novavax to Deliver 100M Doses of Potential COVID-19 Vaccine by 2021

At $1.6 billion, Novavax receives the largest amount the Trump administration has awarded to a company to manufacture millions of doses of a coronavirus vaccine set to be delivered by January...

Credit: Veuer     Duration: 01:20Published
WHO aims to deliver 2B vaccine doses by the end of 2021 [Video]

WHO aims to deliver 2B vaccine doses by the end of 2021

The World Health Organization is working to deliver 2 billion doses of COVID-19 vaccines by the end of 2021. The organization announced the new goal was set this morning. About half of the doses are..

Credit: KTNV Channel 13 Las Vegas     Duration: 00:38Published